A clinical trial to study the comparison between propofol and etomidate for the insertion of laryngeal mask airway in 18 to 60 years of patients with ASA grade I and II

Comparison of propofol and etomidate for the insertion of laryngeal mask airway

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/03/012886

Enrollment

Registered

2018-03-27

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- ASA GRADE I AND II OF 18-60 YEARS WITHOUT HAEMODYNAMIC INSTABILITY AND COMORBIDITIES

Interventions

Control Intervention1: Propofol: 1.dose is 2-2.5mg /kg 2.Iv route Control Intervention2: Etomidate: 1.induction dose 0.2mg/kg 2.Iv route til the effect appears

Eligibility

Inclusion criteria

Inclusion criteria: 1.all day care surgeries for general anaesthesia 2.ASAgrade I AND II

Exclusion criteria

Exclusion criteria: Patients with haemodynamic instability with comorbidities,ASA grade III and IV, patients at risk of regurgitation, with any known allergy to propofol and etomidate, with glucocorticoid insufficiency

Design outcomes

Secondary

Measure	Time frame
ease of insertion , number of attempts, apnoea time ,ease of recoveryTimepoint: 5 minutes	—

Primary

Measure	Time frame
heart rate ,non invasive blood pressure,spo2Timepoint: 5 minutes	—

Countries

India

Contacts

Public ContactDr Ankita Gupta

Peoples college of medical science and research centre

Jainabhilekh@rediffmail.com9827606268

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026